首页> 外文期刊>International journal of surgical pathology >Incidence of Clear Cell Papillary Renal Cell Carcinoma in Low-Grade Renal Cell Carcinoma Cases: A 12-Year Retrospective Clinicopathologic Study From a Single Cancer Center
【24h】

Incidence of Clear Cell Papillary Renal Cell Carcinoma in Low-Grade Renal Cell Carcinoma Cases: A 12-Year Retrospective Clinicopathologic Study From a Single Cancer Center

机译:低级肾细胞癌病例中透明细胞乳头状肾细胞癌的发病率:来自单一癌症中心的12年回顾性临床病理研究

获取原文
获取原文并翻译 | 示例
           

摘要

Clear cell papillary renal cell carcinoma (CCPRCC) is a recently recognized subtype of renal cell carcinoma entity after 2004 World Health Organization classification of renal tumors. CCPRCC has unique histomorphological and immunohistochemical characteristics. The distinction of CCPRCC from renal cell carcinoma (RCC) with clear cell morphology is crucial because the former is considered to have a favorable clinical outcome. CCPRCC may be interpreted in the past as other renal cell carcinomas, particularly low-grade clear cell RCC. In this study, the frequency of CCPRCC in previously diagnosed low-grade RCC and its clinicopathologic features were examined. A total of 126 cases of stage T1a with low nuclear grade RCC were identified from 625 consecutive RCCs removed by radical/partial nephrectomy over 12-year period (2000-2011). Archival tissue sections were retrospectively reviewed along with patient medical charts. Eight cases (1.3% of all RCC, 6.3% of pT1a low grade RCC) with characteristic histologic features of CCPRCC were confirmed by immunohistochemical studies. Seven cases were previously diagnosed as clear cell RCC and one as multilocular cystic RCC. Radiographically, CCPRCC favored a mid-pole location in the kidneys. At a median follow-up period of 52 months (range 20-114.5 months), there were no cases of local or distant recurrence. In conclusion, CCPRCC is not uncommon among small low-grade RCC tumors. CCPRCC can be correctly recognized by its unique histomorphological features and confirmed by immunohistochemistry studies, which is important due to the excellent clinical outcome following resection.
机译:透明细胞乳头状肾细胞癌(CCPRCC)是继2004年世界卫生组织对肾肿瘤进行分类后,最近公认的肾细胞癌实体亚型。 CCPRCC具有独特的组织形态学和免疫组织化学特征。 CCPRCC与具有清晰细胞形态的肾细胞癌(RCC)的区别至关重要,因为前者被认为具有良好的临床效果。 CCPRCC过去可能被解释为其他肾细胞癌,特别是低级透明细胞RCC。在这项研究中,检查了先前诊断为低级RCC的CCPRCC的频率及其临床病理特征。在12年期间(2000-2011年),从625例经根治性/部分肾切除术切除的连续RCC中,共鉴定出126例T1a期低核级RCC。回顾性检查档案组织切片以及患者病历。免疫组化研究证实了八例(CCRCC具有典型组织学特征的RCC,占所有RCC的1.3%,pT1a低级RCC的占6.3%)。先前已诊断出7例为透明细胞RCC,1例为多眼囊性RCC。放射学上,CCPRCC支持在肾脏中极定位。中位随访期为52个月(范围20-114.5个月),没有局部或远处复发病例。总之,CCPRCC在小型低度RCC肿瘤中并不罕见。 CCPRCC可以通过其独特的组织形态学特征正确识别,并可以通过免疫组织化学研究加以证实,这是重要的,因为切除后的临床效果非常好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号